kinase inhibitor UCT-01-097
Term · Oncology and biomedicine · MLC-T-ONC-014645
An orally bioavailable kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor UCT-01-097 may target, bind to and inhibit the activity of one or more kinases that play a key role in tumor cell proliferation.
| Identifier | MLC-T-ONC-014645 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014645",
"term": "kinase inhibitor UCT-01-097",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor UCT-01-097 may target, bind to and inhibit the activity of one or more kinases that play a key role in tumor cell proliferation.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/kinase-inhibitor-uct-01-097/"
}
Record 9,784 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.